FluLaval

Bexsero propels GSK's vaccines unit to 16% growth in Q1

GSK's meningitis vaccine fueled vaccines growth that far outpaced the company's pharma unit, and a new plant and forthcoming launch could keep the momentum going.

Eric Sagonowsky May 1, 2017 6:44am

GSK yanks all doses of quadrivalent flu jab for potency problems

Apr 20, 2015 11:11am